The Georgian Health Digest: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The Georgian Health Digest.

Press releases published on October 30, 2026

2 hours ago

Canon Medical and Stereotaxis Collaborate to Advance Robotic Electrophysiology

Indeterminate GlobeNewswire

2 hours ago

Aer Therapeutics Announces Top-Line Results from its Phase 2a Proof-of-Concept Trial of Fexlamose in Chronic Obstructive Pulmonary Disease (“COPD”)

Indeterminate GlobeNewswire

2 hours ago

Vor Bio Reports Third Quarter 2026 Financial Results and Provides Corporate Update

Indeterminate GlobeNewswire

2 hours ago

Profound Medical and Cook Medical’s iMRI Division Partner to Expand U.S. TULSA-PRO® Sales Channels and Drive Recurring Revenue Growth

Indeterminate GlobeNewswire

2 hours ago

Eos SENOLYTIX Reports Interim Data Showing Preserved Physical Function with MitoXcel Geropeptide PTC-2105 in a Second Species, Aged-Rat Study

Indeterminate GlobeNewswire

2 hours ago

Allarity Therapeutics Secures First Commercial Agreement Under New CLIA Laboratory Services Strategy, Establishing Potential Path to Additional Recurring Revenue

Indeterminate GlobeNewswire

2 hours ago

Braveheart Bio to Host Webinar – HCM Spotlight: Advancing a Next-Generation Cardiac Myosin Inhibitor – with Key Opinion Leader Discussion on November 6, 2026

Indeterminate GlobeNewswire

2 hours ago

Braveheart Bio Announces Upcoming Presentations at the American Heart Association Scientific Sessions 2026

Indeterminate GlobeNewswire

3 hours ago

Alterity Therapeutics Releases Appendix 4C – Q1 FY27 Quarterly Cash Flow Report & Corporate Update

Indeterminate GlobeNewswire

3 hours ago

Syndax Announces Participation in November Investor Conferences

Indeterminate GlobeNewswire

3 hours ago

Acumen Pharmaceuticals Announces Topline Results from Phase 2 ALTITUDE-AD Clinical Trial of Sabirnetug (ACU193) for the Treatment of Early Alzheimer’s Disease; Trial Did Not Meet Primary Endpoint

Indeterminate GlobeNewswire

3 hours ago

NRx Pharmaceuticals (Nasdaq:NRXP) Receives FDA Approval of Preservative-Free Ketamine Ahead of November 10 FDA Goal Date

Indeterminate GlobeNewswire

3 hours ago

Fractyl Health Strengthens Revita Patent Portfolio as It Advances Toward FDA Submission and Potential Commercialization

Indeterminate GlobeNewswire

3 hours ago

Agios Announces New PDUFA Goal Date of February 1, 2027, for Mitapivat Sickle Cell Disease sNDA; Company Is Launch-Ready and in Labeling Discussions with FDA

Indeterminate GlobeNewswire

3 hours ago

Regeneron Reports Third Quarter 2026 Financial and Operating Results

Indeterminate GlobeNewswire

4 hours ago

Glass-Ceramics Market to Reach $2.7 Billion by 2031 as Semiconductor, Aerospace and Medical Applications Expand

Indeterminate GlobeNewswire

4 hours ago

Kestra Medical Technologies to Participate in Upcoming Investor Conferences

Indeterminate GlobeNewswire

4 hours ago

BrightSpring Health Services, Inc. Reports Third Quarter 2026 Financial Results and Increases Full Year 2026 Guidance

Indeterminate GlobeNewswire

4 hours ago

Repligen Announces $1 Billion Private Convertible Senior Notes Transaction

Indeterminate GlobeNewswire

5 hours ago

Asia-Pacific is rapidly gaining importance as a major pillar in global life science innovation

Indeterminate GlobeNewswire